Viveve Medical (VIVE) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VIVE vs. NMRD, AFIB, MOTS, UTRS, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, and CTCXWShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Acutus Medical (AFIB), Motus GI (MOTS), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Its Competitors Nemaura Medical Acutus Medical Motus GI Minerva Surgical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Carmell Viveve Medical (NASDAQ:VIVE) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends. Do institutionals and insiders believe in VIVE or NMRD? 4.4% of Nemaura Medical shares are owned by institutional investors. 5.7% of Viveve Medical shares are owned by insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, VIVE or NMRD? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViveve Medical$6.83M0.00N/AN/AN/ANemaura Medical$3.02K1.34-$14.14M-$0.390.00 Is VIVE or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Viveve MedicalN/A N/A N/A Nemaura Medical N/A N/A N/A Does the media prefer VIVE or NMRD? In the previous week, Viveve Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Viveve Medical Neutral Nemaura Medical Neutral Which has more risk and volatility, VIVE or NMRD? Viveve Medical has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. SummaryNemaura Medical beats Viveve Medical on 3 of the 4 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$35.10M$5.61B$9.30BDividend YieldN/AN/A4.23%4.03%P/E RatioN/A3.0928.5219.58Price / SalesN/A233.75426.1793.37Price / CashN/A41.3636.0257.93Price / BookN/A1.978.135.54Net IncomeN/A-$2.66M$3.24B$257.73M Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/AN/AN/AN/A$1K$6.83M0.0070NMRDNemaura Medical1.1537 of 5 starsN/AN/A-99.7%$4K$3.02K0.0040AFIBAcutus MedicalN/A$0.00-95.0%N/A-92.7%$3K$7.16M0.00340News CoverageGap UpHigh Trading VolumeMOTSMotus GIN/A$0.00flatN/A-99.4%$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160DRTSWAlpha Tau MedicalN/A$0.27-1.8%N/A+9.2%$0.00N/A0.0080ANZUWAnzu Special Acquisition Corp IN/A$0.06+28.3%N/A-27.1%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02-13.9%N/A-65.4%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$15.00+11.1%N/A-78.6%$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/A-70.3%$0.00$32.84K0.0014Gap Up Related Companies and Tools Related Companies Nemaura Medical Competitors Acutus Medical Competitors Motus GI Competitors Minerva Surgical Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Carmell Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIVE Stock Alerts